Guangzhou Innogen Pharmaceutl Grp Co Ltd (02591.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.9x

Market Cap

HKD 1.59B

MomentumView details →

1D Return

−0.14%

YTD Return

−88.27%

RSI (14)

21.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.9x

Market Cap

HKD 1.59B

RSI (14)

21.3

MomentumView details →

1D Return

−0.14%

YTD Return

−88.27%

ProfitabilityView details →

Gross Margin

75.98%

Net Margin

−266.85%

EBITDA Margin

−255.95%

ROE (TTM)

−58.44%

ROA (TTM)

−42.35%

Asset Turnover

0.14x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−100.00%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−HKD 0.29

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.16x

Current Ratio

3.50x

Quick Ratio

3.15x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

206.26M

Net Income (TTM)

−550.40M

Op. CF (TTM)

−513.65M

Latest newsMore news →

Yinuo Medical (B) announced its interim results for the six months ended June 2026, with revenue up 38.6% year-on-year and net loss narrowing to RMB 115 million.10d ago

Silverno Pharma announced it has built an internal AI-driven drug discovery closed loop using proprietary wet-lab data, producing novel large and small molecule entities advancing toward preclinical validation.12d ago

Similar companies

LB Pharmaceuticals Inc Common StockLBRX NewAmsterdam Pharma Company N.V.NAMSW SinoMab BioScience Limited03681.HK HighTide Therapeutics Inc02511.HK RAPT Therapeutics, Inc.RAPT Xeris Biopharma Holdings, Inc.XERS Find similar companies →

Latest newsMore news →

Yinuo Medical (B) announced its interim results for the six months ended June 2026, with revenue up 38.6% year-on-year and net loss narrowing to RMB 115 million.10d ago Silverno Pharma announced it has built an internal AI-driven drug discovery closed loop using proprietary wet-lab data, producing novel large and small molecule entities advancing toward preclinical validation.12d ago